Crossref
Cancer immunotherapy through the ages: Historical development, current role and future perspectives in triple-negative breast cancer
World Journal of Clinical Oncology · 05.11.2026
DOI: 10.5306/wjco.127473 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 05.11.2026. Verfasst von Adam Afife und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Afife, A., & Baraka, B. (2026). Cancer immunotherapy through the ages: Historical development, current role and future perspectives in triple-negative breast cancer. World Journal of Clinical Oncology. https://doi.org/10.5306/wjco.127473
Vancouver
Afife A, Baraka B. Cancer immunotherapy through the ages: Historical development, current role and future perspectives in triple-negative breast cancer. World Journal of Clinical Oncology. 2026. doi:10.5306/wjco.127473
BibTeX
@article{Afife2026,
author = {Afife, Adam and Baraka, Bahaaeldin},
title = {Cancer immunotherapy through the ages: Historical development, current role and future perspectives in triple-negative breast cancer},
journal = {World Journal of Clinical Oncology},
year = {2026},
doi = {10.5306/wjco.127473}
}
EUVIMED